This information was provided by prnewswire
Send your Press Release here.
VAUGHAN, ON, Oct. 31, 2018 /CNW/ – CannTrust Holdings Inc. (“CannTrust” or the “Company” | TSX: TRST), a licensed producer of cannabis, is pleased to announce the appointment of John T. Kaden as a Director of the Company.
John T. Kaden is the co-Founder, Managing Partner and Chief Investment Officer of Navy Capital Green Management LLC., a global investment firm specializing in public and private investments in the emerging legal cannabis industry. Prior to this, Mr. Kaden was the co-Manager and Chief Investment Officer for Northwoods Capital Management LLC, a TMT-focused global hedge fund. Prior to joining Northwoods, Mr. Kaden was the Founder and Managing Partner of Cynthion Partners, a global macro hedge fund, from 2006 through the end of 2013. Prior to founding Cynthion, Mr. Kaden was an Associate in the Strategic Division of Blackrock. Mr. Kaden began his career as a macro strategist for The G7 Group, a global consulting firm that advises its clients on macroeconomic and political developments that affect financial markets. Mr. Kaden graduated Magna Cum Laude with an A.B. from Harvard University and a J.D. from Yale Law School.
“I am delighted to join the board of CannTrust which I believe is positioned to be one of the leading companies, not only in Canada’s medical and recreational cannabis markets, but also among the earliest multinational corporations positioned to lead this rapidly emerging global industry,” said John T. Kaden, Managing Partner and Chief Investment Officer, Navy Capital, LLC.
“I have known John for over two years and appreciate his vision, industry depth and capital markets expertise. We look forward to his guidance as we continue our rapid expansion in Canada and the global medical markets,” said Eric Paul, CannTrust’s Co-Founder and Chairman of the Board.
CannTrust – a front-runner in the cannabis industry, a federally regulated licensed producer and proudly a Canadian company – is leading the Canadian and global market in producing standardized cannabis products. Started as Canada’s only pharmacist-founded medical cannabis producer, CannTrust brings more than 40 years of pharmacy and healthcare experience to the medical cannabis industry. CannTrust currently operates its 450,000 sq. ft. Niagara Perpetual Harvest Facility. The 600,000 sq. ft. greenhouse expansion has begun and is fully funded. The industry’s broadest product portfolio is prepared and packaged at the 60,000 sq. ft. manufacturing Centre of excellence in Vaughan, Ontario.
CannTrust is ready for Cannabis 2.0, and is currently developing new products for future verticals that span the medical, recreational, beauty, wellness and pet markets. CannTrust is committed to research and innovation, as well as contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis. Its product development teams along with its exclusive global pharma partner, Apotex Inc., are diligently innovating and developing products that will make it easier for patients to use medical cannabis. CannTrust supports ongoing patient education about medical cannabis and has a compassionate use program to support patients with financial needs.
Leave a Reply